Jiaxue He
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine 3
-
- PARP inhibition in cancer therapy 3
-
- Ferroptosis and cancer prognosis 2
- Lung Cancer Treatments and Mutations 2
-
- RNA modifications and cancer 2
-
- SARS-CoV-2 and COVID-19 Research 1
-
- Bacteriophages and microbial interactions 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Journals
- PLoS ONE (1 paper)Biochemical and Biophysical Research Communications (1 paper)Journal of Bone and Mineral Research (1 paper)
- Partner nations
- ChinaSwedenSaint Kitts and Nevis
In The Last Decade
Jiaxue He
12 papers receiving 248 citations
Peers
Comparison fields: 5 of 59
- Geriatrics and Gerontology 41
- Epidemiology 94
- Physiology 11
- Cancer Research 25
- Orthopedics and Sports Medicine 14
Countries citing papers authored by Jiaxue He
This map shows the geographic impact of Jiaxue He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxue He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxue He more than expected).
Fields of papers citing papers by Jiaxue He
This network shows the impact of papers produced by Jiaxue He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxue He. The network helps show where Jiaxue He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiaxue He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 0 | |
| 4 | 2022 | 0 | |
| 5 | 2021 | 18 | |
| 6 | 2020 | 16 | |
| 7 | 2020 | 33 | |
| 8 | 2020 | 2 | |
| 9 | 2019 | 5 | |
| 10 | 2017 | 7 | |
| 11 | 2017 | 30 | |
| 12 | 2016 | 31 | |
| 13 | 2013 | 27 | |
| 14 | 2011 | 76 |
About Jiaxue He
Jiaxue He is a scholar working on Geriatrics and Gerontology, Cancer Research and Oncology, having authored 14 papers that have together received 248 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (3 papers), PARP inhibition in cancer therapy (3 papers), Ferroptosis and cancer prognosis (2 papers), RNA modifications and cancer (2 papers), Lung Cancer Treatments and Mutations (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Bacteriophages and microbial interactions (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Geriatrics and Gerontology (41 citations), Epidemiology (94 citations) and Physiology (11 citations). Jiaxue He has collaborated with scholars based in China, Sweden and Saint Kitts and Nevis. Frequent co-authors include Xu He, Urban Lindgren, Yanfang Jiang, Göran Andersson, Björn Anderstam, Yulin Li, Yan Li, Sijia Hao, Chunyan Wang and Siwen Liu. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.